Subscribe To
Find strong stocks for 2022 with return on equity
Today, we utilized a Zacks screen to help find highly-ranked stocks that have proven they can turn asse...
December 21, 2021, 8:42 pm
Find strong stocks for 2022 with return on equity
Today, we utilized a Zacks screen to help find highly-ranked stocks that have proven they can turn asse...
December 21, 2021, 8:42 pm
Find strong stocks for 2022 with return on equity
Today, we utilized a Zacks screen to help find highly-ranked stocks that have proven they can turn asse...
December 21, 2021, 8:42 pm
Novartis' new kisqali data shows consistent overall survival benefit across metastatic breast cancer settings
Novartis AG (NYSE: NVS) shared new data from the MONALEESA Phase 3 program of Kisqali (ribociclib), the CDK4/6 inhibitor in HR+/HER2- metastatic br...
December 8, 2021, 1:27 pm
Novartis' new kisqali data shows consistent overall survival benefit across metastatic breast cancer settings
Novartis AG (NYSE: NVS) shared new data from the MONALEESA Phase 3 program of Kisqali (ribociclib), the CDK4/6 inhibitor in HR+/HER2- metastatic br...
December 8, 2021, 1:27 pm
Novartis' new kisqali data shows consistent overall survival benefit across metastatic breast cancer settings
Novartis AG (NYSE: NVS) shared new data from the MONALEESA Phase 3 program of Kisqali (ribociclib), the CDK4/6 inhibitor in HR+/HER2- metastatic br...
December 8, 2021, 1:27 pm
Metlife: proven business model with a 3.08% dividend yield
MetLife posted good 3rd quarter results outperforming the estimates. Their business model is stable and proven...
November 27, 2021, 6:40 am
Metlife: proven business model with a 3.08% dividend yield
MetLife posted good 3rd quarter results outperforming the estimates. Their business model is stable and proven...
November 27, 2021, 6:40 am
Metlife: proven business model with a 3.08% dividend yield
MetLife posted good 3rd quarter results outperforming the estimates. Their business model is stable and proven...
November 27, 2021, 6:40 am
Amazon care inks deal with hilton, yet again proving its might in innovative disruption
As Amazon has proven across nearly all other industries, it will undoubtedly be a force to reckon with ...
November 23, 2021, 10:19 pm
Amazon care inks deal with hilton, yet again proving its might in innovative disruption
As Amazon has proven across nearly all other industries, it will undoubtedly be a force to reckon with ...
November 23, 2021, 10:19 pm
Amazon care inks deal with hilton, yet again proving its might in innovative disruption
As Amazon has proven across nearly all other industries, it will undoubtedly be a force to reckon with ...
November 23, 2021, 10:19 pm
Kyndryl - unwanted and undervalued
Kyndryl was recently spun out of IBM and is down sharply in only three weeks of trading. KD addresses a mediocre market and is not a pr...
November 23, 2021, 1:18 pm
Kyndryl - unwanted and undervalued
Kyndryl was recently spun out of IBM and is down sharply in only three weeks of trading. KD addresses a mediocre market and is not a pr...
November 23, 2021, 1:18 pm
Kyndryl - unwanted and undervalued
Kyndryl was recently spun out of IBM and is down sharply in only three weeks of trading. KD addresses a mediocre market and is not a pr...
November 23, 2021, 1:18 pm
Arbutus biopharma: recent acquisition of dicerna makes it an attractive investment
Recent Acquisition of RNAi drug maker Dicerna by Novo Nordisk makes a case for eventual partnership/buyout of Arbutus Biopharma. AB-729 has pr...
November 19, 2021, 7:29 pm
Arbutus biopharma: recent acquisition of dicerna makes it an attractive investment
Recent Acquisition of RNAi drug maker Dicerna by Novo Nordisk makes a case for eventual partnership/buyout of Arbutus Biopharma. AB-729 has pr...
November 19, 2021, 7:29 pm
Arbutus biopharma: recent acquisition of dicerna makes it an attractive investment
Recent Acquisition of RNAi drug maker Dicerna by Novo Nordisk makes a case for eventual partnership/buyout of Arbutus Biopharma. AB-729 has pr...
November 19, 2021, 7:29 pm
Bioventus inc. (bvs) ceo ken reali on q3 2021 results - earnings call transcript
Bioventus Inc. (BVS) CEO Ken Reali on Q3 2021 Results - Earnings Call Transcript...
November 14, 2021, 11:45 am
Bioventus inc. (bvs) ceo ken reali on q3 2021 results - earnings call transcript
Bioventus Inc. (BVS) CEO Ken Reali on Q3 2021 Results - Earnings Call Transcript...
November 14, 2021, 11:45 am